Showing results (341-350 of 556) with videos related to
Sort By:
Pageof 56
The Oncologist|May 24, 2017
Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate DataPetr Szturz, Kristien Wouters, Naomi Kiyota, et al.Journal of Cancer Research and Therapeutics|July 29, 2020
Head and neck squamous cell carcinoma in HIV, HBV and HCV seropositive patients - Prognosis and its predictorsSupreet Singh Nayyar, Shivakumar Thiagarajan, Akshat Malik, et al.Nuclear Medicine Communications|August 16, 2020
Role of 18F-FDG PET/CT in restaging of esophageal cancer after curative-intent surgical resectionShantanu S Pande, Nilendu Purandare, Ameya Puranik, et al.Journal of Cachexia, Sarcopenia and Muscle|July 8, 2016
Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non-small cell lung cancer or colorectal cancer: a randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial)Andrew J Stewart Coats, Gwo Fuang Ho, Kumar Prabhash, et al.Oncotargets and Therapy|April 14, 2017
EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?Amit Joshi, Saurabh Zanwar, Vanita Noronha, et al.Indian Journal of Cancer|August 8, 2018
Efficacy of crizotinib in ALK mutant non-small cell lung cancers that are positive by IHC but negative by FISH compared to FISH positive casesSaurabh Zanwar, Vanita Noronha, Amit Joshi, et al.International Journal of Radiation Oncology, Biology, Physics|April 1, 2008
Nasopharyngeal carcinoma in children: comparison of conventional and intensity-modulated radiotherapySiddhartha Laskar, Gaurav Bahl, Maryann Muckaden, et al.Journal for Immunotherapy of Cancer|May 23, 2020
Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: an implication for anti-CD38 immunotherapyPrashant Ramesh Tembhare, Harshini Sriram, Twinkle Khanka, et al.South Asian Journal of Cancer|January 2, 2023
Prognostic Impact of Baseline Liver Metastasis in ALK Fusion-Positive Metastatic Lung Cancer: A Retrospective ReviewSatvik Khaddar, Akhil Kapoor, Vanita Noronha, et al.Auris, Nasus, Larynx|December 31, 2018
Utility of response assessment PET-CT to predict residual disease in neck nodes: A comparison with the HistopathologyKhuzema Saifuddin Fatehi, Shivakumar Thiagarajan, Harsh Dhar, et al.Pageof 56